TY - JOUR
T1 - Whole-exome sequencing for variant discovery in blepharospasm
AU - Tian, Jun
AU - Vemula, Satya R.
AU - Xiao, Jianfeng
AU - Valente, Enza Maria
AU - Defazio, Giovanni
AU - Petrucci, Simona
AU - Gigante, Angelo Fabio
AU - Rudzińska-Bar, Monika
AU - Wszolek, Zbigniew K.
AU - Kennelly, Kathleen D.
AU - Uitti, Ryan J.
AU - van Gerpen, Jay A.
AU - Hedera, Peter
AU - Trimble, Elizabeth J.
AU - LeDoux, Mark S.
N1 - Funding Information:
National Institute of Neurological Disorders and Stroke, Grant/Award Number: P50 NS072187, R01 NS082296, R21 GM118962, R56 NS094965; National Institute on Aging, Grant/Award Number: 1U01AG045390-01A1; U.S. Department of Defense, Grant/Award Number: W81XWH-17-1-0062; Benign Essential Blepharospasm Research Foundation; Neuroscience Institute at the University of Tennessee Health Science Center (UHTSC); UTHSC iRISE Pilot Translational and Clinical Studies Program; Dorothy/Daniel Gerwin Parkinson Research Fund; Mayo Clinic Center for Regenerative Medicine; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Neuroscience Focused Research Team; Cecilia and Dan Carmichael Family Foundation; James C. and Sarah K. Kennedy Fund for Neurodegenerative Disease Research at Mayo Clinic in Florida
Funding Information:
Our utmost thanks go to the many families who participated in this study. M.S.L. was supported by the Benign Essential Blepharospasm Research Foundation, Neuroscience Institute at the University of Tennessee Health Science Center (UHTSC), UTHSC iRISE Pilot Translational and Clinical Studies Program, Dorothy/Daniel Gerwin Parkinson Research Fund, Department of Defense grant W81XWH-17-1-0062 and National Institutes of Health (NIH) grants R01 NS082296, R21 GM118962, and R56 NS094965. Z.K.W. was partially supported by the NIH/National Institute of Neurological Diseases and Stroke (NINDS) P50 NS072187, NIH/National Institute of Aging (NIA) (primary) and NIH/ NINDS (secondary) 1U01AG045390-01A1, Mayo Clinic Center for Regenerative Medicine, Mayo Clinic Center for Individualized Medicine, Mayo Clinic Neuroscience Focused Research Team (Cecilia and Dan Carmichael Family Foundation, and the James C. and Sarah K. Kennedy Fund for Neurodegenerative Disease Research at Mayo Clinic in Florida), a gift from Carl Edward Bolch, Jr., and Susan Bass Bolch, The Sol Goldman Charitable Trust, and Donald G. and Jodi P. Heeringa. At the University of Tennessee Health Science Center, Vanisha Patel participated in Sanger sequencing and quantitative PCR. At the Mayo Clinic Florida, Audrey Strongosky and Anne Martin participated in the collection of blood samples and phenotypic information.
Funding Information:
Our utmost thanks go to the many families who participated in this study. M.S.L. was supported by the Benign Essential Blepharospasm Research Foundation, Neuroscience Institute at the University of Tennessee Health Science Center (UHTSC), UTHSC iRISE Pilot Translational and Clinical Studies Program, Dorothy/Daniel Gerwin Parkinson Research Fund, Department of Defense grant W81XWH-17-1-0062 and National Institutes of Health (NIH) grants R01 NS082296, R21 GM118962, and R56 NS094965. Z.K.W. was partially supported by the NIH/National Institute of Neurological Diseases and Stroke (NINDS) P50 NS072187, NIH/National Institute of Aging (NIA) (primary) and NIH/NINDS (secondary) 1U01AG045390-01A1, Mayo Clinic Center for Regenerative Medicine, Mayo Clinic Center for Individualized Medicine, Mayo Clinic Neuroscience Focused Research Team (Cecilia and Dan Carmichael Family Foundation, and the James C. and Sarah K. Kennedy Fund for Neurodegenerative Disease Research at Mayo Clinic in Florida), a gift from Carl Edward Bolch, Jr., and Susan Bass Bolch, The Sol Goldman Charitable Trust, and Donald G. and Jodi P. Heeringa. At the University of Tennessee Health Science Center, Vanisha Patel participated in Sanger sequencing and quantitative PCR. At the Mayo Clinic Florida, Audrey Strongosky and Anne Martin participated in the collection of blood samples and phenotypic information.
Publisher Copyright:
© 2018 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
PY - 2018/7
Y1 - 2018/7
N2 - Background: Blepharospasm (BSP) is a type of focal dystonia characterized by involuntary orbicularis oculi spasms that are usually bilateral, synchronous, and symmetrical. Despite strong evidence for genetic contributions to BSP, progress in the field has been constrained by small cohorts, incomplete penetrance, and late age of onset. Although several genetic etiologies for dystonia have been identified through whole-exome sequencing (WES), none of these are characteristically associated with BSP as a singular or predominant manifestation. Methods: We performed WES on 31 subjects from 21 independent pedigrees with BSP. The strongest candidate sequence variants derived from in silico analyses were confirmed with bidirectional Sanger sequencing and subjected to cosegregation analysis. Results: Cosegregating deleterious variants (GRCH37/hg19) in CACNA1A (NM_001127222.1: c.7261_7262delinsGT, p.Pro2421Val), REEP4 (NM_025232.3: c.109C>T, p.Arg37Trp), TOR2A (NM_130459.3: c.568C>T, p.Arg190Cys), and ATP2A3 (NM_005173.3: c.1966C>T, p.Arg656Cys) were identified in four independent multigenerational pedigrees. Deleterious variants in HS1BP3 (NM_022460.3: c.94C>A, p.Gly32Cys) and GNA14 (NM_004297.3: c.989_990del, p.Thr330ArgfsTer67) were identified in a father and son with segmental cranio-cervical dystonia first manifest as BSP. Deleterious variants in DNAH17, TRPV4, CAPN11, VPS13C, UNC13B, SPTBN4, MYOD1, and MRPL15 were found in two or more independent pedigrees. To our knowledge, none of these genes have previously been associated with isolated BSP, although other CACNA1A mutations have been associated with both positive and negative motor disorders including ataxia, episodic ataxia, hemiplegic migraine, and dystonia. Conclusions: Our WES datasets provide a platform for future studies of BSP genetics which will demand careful consideration of incomplete penetrance, pleiotropy, population stratification, and oligogenic inheritance patterns.
AB - Background: Blepharospasm (BSP) is a type of focal dystonia characterized by involuntary orbicularis oculi spasms that are usually bilateral, synchronous, and symmetrical. Despite strong evidence for genetic contributions to BSP, progress in the field has been constrained by small cohorts, incomplete penetrance, and late age of onset. Although several genetic etiologies for dystonia have been identified through whole-exome sequencing (WES), none of these are characteristically associated with BSP as a singular or predominant manifestation. Methods: We performed WES on 31 subjects from 21 independent pedigrees with BSP. The strongest candidate sequence variants derived from in silico analyses were confirmed with bidirectional Sanger sequencing and subjected to cosegregation analysis. Results: Cosegregating deleterious variants (GRCH37/hg19) in CACNA1A (NM_001127222.1: c.7261_7262delinsGT, p.Pro2421Val), REEP4 (NM_025232.3: c.109C>T, p.Arg37Trp), TOR2A (NM_130459.3: c.568C>T, p.Arg190Cys), and ATP2A3 (NM_005173.3: c.1966C>T, p.Arg656Cys) were identified in four independent multigenerational pedigrees. Deleterious variants in HS1BP3 (NM_022460.3: c.94C>A, p.Gly32Cys) and GNA14 (NM_004297.3: c.989_990del, p.Thr330ArgfsTer67) were identified in a father and son with segmental cranio-cervical dystonia first manifest as BSP. Deleterious variants in DNAH17, TRPV4, CAPN11, VPS13C, UNC13B, SPTBN4, MYOD1, and MRPL15 were found in two or more independent pedigrees. To our knowledge, none of these genes have previously been associated with isolated BSP, although other CACNA1A mutations have been associated with both positive and negative motor disorders including ataxia, episodic ataxia, hemiplegic migraine, and dystonia. Conclusions: Our WES datasets provide a platform for future studies of BSP genetics which will demand careful consideration of incomplete penetrance, pleiotropy, population stratification, and oligogenic inheritance patterns.
KW - Purkinje cell
KW - blepharospasm
KW - cerebellum
KW - dystonia
KW - whole-exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85047660709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047660709&partnerID=8YFLogxK
U2 - 10.1002/mgg3.411
DO - 10.1002/mgg3.411
M3 - Article
AN - SCOPUS:85047660709
SN - 2324-9269
VL - 6
SP - 601
EP - 626
JO - Molecular Genetics and Genomic Medicine
JF - Molecular Genetics and Genomic Medicine
IS - 4
ER -